4ET-1103

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug Name4ET-1103
Drug Alias Name4ET11034ET-1103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitorsMAP kinase-interacting serine/threonine-protein kinase 2 inhibitors
TargetsMAP kinase-interacting serine/threonine-protein kinase 2MAP kinase-interacting serine/threonine-protein kinase MNK1
Therapy Area/IndicationsLow Back PainNeuralgiaMigraine Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator Companies4E Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies4E Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLow Back PainNeuralgiaMigraine Disorders +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A